Pawel Przewiezlikowski is the founder of Ryvu. Latest round: Growth. Backed by BioNTech, The Leukemia & Lymphoma Society (LLS). Based in Krakow, Poland.
Paweł Przewiężlikowski is a Polish businessman, co-founder and CEO of the biotechnology company Ryvu Therapeutics, formerly known as Selvita. Ryvu Therapeutics focuses on developing innovative small-molecule compounds with therapeutic potential in oncology. He is also the largest shareholder of the company.
Full founder directory · Investor directory · Company funding database · Fundraising library